Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Endocrinology|October 13, 2009
Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosisMichael K Badman, Anja Koester, Jeffrey S Flier, et al.Biological Psychiatry|February 15, 2003
Involvement of NMDA receptors in alcohol-mediated behavior: mice with reduced affinity of the NMDA R1 glycine binding site display an attenuated sensitivity to ethanolFalk Kiefer, Holger Jahn, Anja Koester, et al.Molecular Vision|June 25, 2004
Differentially expressed genes in the lens of mimecan-null miceElena S Tasheva, An Ke, Youping Deng, et al.Molecular Vision|November 15, 2002
Mimecan/osteoglycin-deficient mice have collagen fibril abnormalitiesElena S Tasheva, Anja Koester, Avelina Q Paulsen, et al.Endocrinology|October 28, 2006
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21Alexei Kharitonenkov, Victor J Wroblewski, Anja Koester, et al.Diabetes/Metabolism Research and Reviews|May 27, 2010
Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion proteinWolfgang Glaesner, Andrew Mark Vick, Rohn Millican, et al.Mabs|June 29, 2018
FcγRIIIa-dependent IFN-γ release in whole blood assay is predictive of therapeutic IgG1 antibodies safetyNada S Alakhras, Jiabin Qiu, Guilherme V Rocha, et al.The Journal of Pharmacology and Experimental Therapeutics|March 31, 2016
In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin AnalogRebecca A Owens, Ryan J Hansen, Steven D Kahl, et al.Plos One|March 29, 2013
Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319Alexei Kharitonenkov, John M Beals, Radmila Micanovic, et al.Biological Psychiatry|February 3, 2016
Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 ReceptorMasaaki Iwata, Kristie T Ota, Xiao-Yuan Li, et al.Pageof 2